Abstract
While knowledge of the population’s view on the need for informed consent for retrospective radiology research may provide valuable insight into how an optimal balance can be achieved between patient rights versus an expedited advancement of radiology science, this is a topic that has been ignored in the literature so far. To investigate the view of the general population, survey data were collected from 2407 people representative of the Dutch population. The results indicate that for non-commercial institutions, especially hospitals (97.4 per cent), respondents agree with the retrospective use of imaging data, although they generally indicate that their explicit consent is required. However, most respondents (63.5 per cent) would never allow commercial firms to retrospectively use their imaging data. When including only respondents who completed the minimally required reading time of 12.3 s to understand the description about retrospective radiology research given in the survey (n = 770), almost all (98.9 per cent) mentioned to have no objections for their imaging data to be used by hospitals for retrospective research, with 57.9 per cent indicating their consent to be required and 41.0 per cent indicating that explicit patient consent to be unnecessary. We conclude that the general population permits retrospective radiology research by hospitals, and a substantial proportion indicates explicit patient consent to be unnecessary when understanding what retrospective radiology research entails. However, the general population’s support for the unrestricted retrospective use of imaging data for research purposes without patient consent decreases for universities not linked to hospitals, other non-commercial institutions, government agencies, and particularly commercial firms.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Research is crucial to advance healthcare, including radiology. Prospective studies, in which subjects undergo a medical imaging procedure that is not part of routine clinical care, require ethical review board approval and informed patient consent (Junod and Elger 2010; Stefánsson, Atladóttir and Gudbjornsson 2008). For retrospective research with previously acquired medical imaging data, ethical review board approval is also considered necessary (Junod and Elger 2010; Stefánsson et al. 2008; De Lange et al. 2019). However, there is no consensus about the need for informed patient consent for retrospective research, with widely varying practices between different countries and institutions (Junod and Elger 2010; Stefánsson et al. 2008; De Lange et al. 2019).
Proponents of informed patient consent for retrospective research argue that this is required to respect patient autonomy and privacy regulations (Junod and Elger 2010; Stefánsson et al. 2008; De Lange et al. 2019; “The HIPAA Privacy Rule” 2022; European Commission 2022). Opponents argue that refraining from informed patient consent will decrease unnecessary bureaucracy and expedite research and knowledge acquisition that may benefit patient care (Junod and Elger 2010; Stefánsson et al. 2008; De Lange et al. 2019). Approaching patients for informed consent could also lead to undesirable situations when a patient suffers from a serious disease or has already deceased. Furthermore, it can be argued that medical imaging data can be adequately anonymized or pseudonymized to respect a patient’s privacy (Milchenko and Marcus 2013). Finally, it can be considered practically impossible to contact many patients in large-scale studies (Junod and Elger 2010; Stefánsson et al. 2008; De Lange et al. 2019). The latter is an important issue in the development of artificial intelligence algorithms that need to be trained with large amounts of data (Pinto Dos Santos and Baeßler, 2018).
So far, the view of the general population on the need for informed consent for retrospective radiology research has not been explored. Gaining knowledge of the population’s view may provide valuable insight into how an optimal balance can be achieved between patient rights versus an expedited advancement of radiology science through retrospective research. It is hypothesized that the majority of subjects have no objections when their deidentified medical imaging data are reused for retrospective research purposes.
The purpose of this study was therefore to investigate the view of the general population on the need for informed patient consent for retrospective radiology research.
Methods
Study Design and Subjects
For this study we collected data in the September 2022 wave of the online LISS Panel (Longitudinal Internet Studies for the Social Sciences). The LISS panel is a nationally representative household panel study for people aged sixteen years and above in the Netherlands. In a subsample (see Table 1 for demographics) we only included panel members of eighteen years and above, and only one member per household for households that have multiple participating members. The informed consent procedure in the LISS panel ensures double consent, via a reply card and an internet login (see Scherpenzeel and Das 2010 for more details). Ethical approval for the procedures in the LISS Panel was given by the board of overseers (LISS Board of Overseers 2022). For the September 2022 wave, 3425 panel members were contacted and 2407 completed the full questionnaire resulting in a 70.3 per cent response rate. Respondents could fill out the survey on a PC, tablet, or smartphone.
The Questionnaire
To investigate the general population’s view on the need for informed patient consent for retrospective radiology research, we included eight questions in the September 2022 wave asking respondents about the re-use of imaging data for this purpose and their experience with clinical radiology. Prior to these questions, respondents were asked several other questions about diagnostic and interventional radiology that were not part of the present study.
Measurement of Agreement with Retrospective Use of Imaging Data for Research
Respondents were first given an explanation of retrospective radiology research and the use of anonymized imaging data for research. Time spent on reading the explanation was measured with time stamps. The text for this explanation was:
Next, we will ask a number of general questions about conducting radiological research with anonymized data (for example, research with X-rays and images from a CT scan). Anonymized means that the data do not contain recognizable personal data of patients. The researchers can therefore not identify the people to whom the data belong.
Hundreds of radiological examinations are performed in every hospital every day. The corresponding images are stored in every hospital, and can be reused for research.
The original Dutch version of the text included eighty words, with an average word length of six letters. Given the fact that the average reading speed of Dutch texts with an average word length of six letters is 202 words per minute (Brysbaert, et al. 2021), we assumed that it would take an average of twenty-four seconds to read the explanation, and the minimum required time for fast readers would be 12.3 s (two standard errors below the average reading time). A separate analysis was conducted for respondents who spent at least 12.3 s on reading the explanation. After the explanation respondents were given the question “If a patient has undergone a diagnostic imaging study, by whom do you think the anonymized information/data from this study may be reused?” Respondents could indicate per type of institution (hospital, university, other non-commercial institution, commercial firms, governmental agencies) whether this institution could use the data; (option 1) without approval of the patient (“permission without explicit patient consent”), (option 2) only with approval of the patient (“permission with explicit patient consent”), or (option 3) not at all (“never permission”). The different types of institutions were offered in a randomized order to counterbalance order effects. The same question was also asked for the interventional radiology setting: “If a patient has undergone an interventional radiology procedure, by whom do you think the anonymized information/data from this study can be reused?”.
Measurement Predictor Variables
As potential predictor variables we investigated gender, level of education, and experience with radiological procedures (either as a patient or as a person accompanying a patient). Level of education was measured with the LISS-panel item of highest earned degree, and for purposes of analysis, categories taken from the Dutch educational system were converted into international categories; primary education, secondary (i.e., pre-university education or mediate vocational education), tertiary (i.e., university or higher vocational education) and other (no degree or degree not included among response options). Respondents were asked whether they had experience with diagnostic radiology, with interventional radiology, and/or being a representative of a friend, acquaintance or family member undergoing imaging studies (for diagnosis or treatment) at a radiology department. If respondents had indicated experience with any of these three situations, they were subsequently asked whether their last experience occurred in the current year, last year, or longer ago.
Statistical Analysis
Agreement of retrospective use of imaging data was measured with categorical response options that are incremental in terms of agreement (i.e., allowing retrospective use of imaging data without explicit approval of the patient is less restrictive than allowing use only with explicit approval, and both are less restrictive than never allowing retrospective use of imaging data). Because of the ordinal level of measurement, we cannot assess the exact level of agreement numerically. Therefore, an ordinal logistic regression was used to assess the effects of the predictor variables on the three levels of agreement of retrospective use of imaging data. To interpret odds ratios we used: > 1.5 (small effect), > 2 (medium effect), > 3 (large effect) and for negative effects the multiplicative inverse (1/x) of the classification was used: < 0.66 (small), < 0.5 (medium), < 0.33 (large) (Sullivan and Feinn, 2012).
Results
Descriptive Statistics
The responses to the question “If a patient has undergone a diagnostic imaging study, by whom do you think the anonymized information/data from this study can be reused?” showed that for non-commercial institutions, especially hospitals (97.4 per cent), respondents agree with the retrospective use of imaging data, although they generally indicate that their explicit consent is required. However, the majority of respondents (63.5 per cent) would never allow commercial firms to retrospectively use their imaging data (Table 2). Responses were analysed separately for respondents with a reading time of 12.3 s or more, to ensure that the description about retrospective radiology research was sufficiently read to be understood. After removing outliers above 1.5 times the interquartile range, the average reading time was 10.1 s (sd = 9.9), and 75 per cent of respondents had a reading time of 16 s or lower. Reading times were significantly different for age (for each year, the amount of time increased with 0.18 s) and education (respondents with a tertiary level of education spent 1.34 times more time on reading than respondents with primary education). When including only respondents (n = 770) with the minimally required reading time of 12.3 s or more, almost all (98.9 per cent) mentioned to have no objections for their imaging data to be used by hospitals for retrospective research, with 57.9 per cent indicating their consent to be required and 41.0 per cent indicating that explicit patient consent to be unnecessary. Note that the size of the latter group (i.e., approval without explicit patient consent) increased by 10 percent points relative to the entire group of respondents (including those with a reading time of less than 12.3 s), and similar increases were found for the other institutions. Responses to the question “If a patient has undergone an interventional radiology procedure, by whom do you think the anonymized information/data from this study can be reused?” showed exactly the same pattern (Supplemental materials, Table 2a).
Ordinal Logistic Regression
Table 3 presents the results of the ordinal logistic regression analysis that was conducted to examine the relationship between various predictor variables and the outcome variable of consent with retrospective use of data in five types of institutions. According to the Akaike information criterion (AIC) and residual variance this model had significant better fit to the data as compared to the same analysis without interaction effects (LR(df = 3) = 26.32, p < 0.001). The table presents the ORs for each predictor variable, along with the corresponding confidence intervals (CIs) and p-values. The analysis shows that “never permission” was far less likely to be chosen than “permission with explicit patient consent,” whereas “permission without explicit patient consent” was much more likely to be chosen than “permission without explicit patient consent.” Furthermore, the institutions (taking the hospital as reference category) have medium negative effects (university; OR = 0.41) or large negative effects (commercial, non-commercial, and government, OR = 0.27, 0.03, 0.26, respectively); i.e., consent is higher for use of data by hospitals than by other types of institutions. Effects of education showed that respondents with secondary and tertiary education were more likely to choose “without approval” than respondents with primary education, showing a medium effect size (OR = 2.41 for tertiary education) and a small effect size (OR = 1.61 for secondary education). In addition, interaction effects between gender and education showed small effects for females with secondary education (OR = 0.56) and tertiary education (OR = 0.62). The odds of choosing “permission without explicit patient consent” were lower for females with secondary or tertiary education, compared to females with primary education, while these odds were higher for males with secondary or tertiary education than for males with primary education. A significant positive effect was found for reading time (the amount of time respondents had spent on reading the explanation of retrospective radiology and storage of anonymized imaging data). Significant negative effects (though negligible in effect size) were found for experience with radiological examinations (respondents with no experience were less likely to choose “permission without explicit patient consent than respondents with experience) and age (the odds of choosing “permission without explicit patient consent” slightly decreased with increasing age). Separate ordinal logistic regression analyses per institution (Table 4) showed that the effect of reading time did not hold for responses for the item on commercial institutions, the effect of education (tertiary versus primary) was largest for the item on the government (OR = 3.92), and the effect of no experience was largest for the item on hospitals, though still a small effect (OR = 0.66). The interaction effect of gender and education was strongest (though still small) for the items on non-commercial institutions, commercial organizations, and the government.
Figures 1, 2, 3 and 4 further illustrate these outcomes for consent with data in the hospital: especially respondents with reading times below twenty seconds were more likely to choose “never permission” or “permission with explicit patient consent” (Figs. 1, and 2). In addition, male respondents were more likely to select “permission without explicit patient consent” than females, whereas females were more likely to choose “never permission” and “permission with explicit patient consent” than males (Fig. 1). Increase in reading time showed increased selection of “permission without explicit patient consent” for all levels of education (Fig. 2). Differences in odds of choosing “never permission” were mostly found for respondents with an unspecified level of education (Figs. 2 and 3) and for respondent with no experience in radiological examination, for whom the odds of choosing “never permission” appeared to increase with age (Fig. 4). Selection of “permission without explicit patient consent” seemed to slightly decrease with increasing age, but there was a contrast between tertiary versus other levels of education (Fig. 3). The supplemental materials (Figs. 1a–2e) include figures illustrating outcomes for all five institutions.
Discussion
The results of this study show that the view of the general population on the retrospective use of diagnostic imaging data for research purposes is variable, depending on the setting. Although the vast majority would allow hospitals to perform retrospective research with diagnostic imaging data (97.4 per cent), this proportion drops somewhat for universities (89.7 per cent), other non-commercial institutions (82.4 per cent), and government agencies (79.5 per cent), while only a minority would allow commercial firms to use their diagnostic imaging data (36.5 per cent). This finding may be explained by the fact that patients already have a relationship with their hospital based on some degree of trust and that this trust decreases in institutions with which such a relationship did not exist. It also shows that government agencies are not completely trusted, especially by respondents with primary education as highest level of education completed, and that faith in for-profit companies is generally lacking. Another finding of this study is that the majority of participants indicated their explicit consent to be required before any diagnostic imaging data can be used for retrospective research. Importantly, however, whether or not participants deemed consent necessary depended on two variables, namely the time spent on reading the explanation about retrospective radiology research in this survey and level of education. Participants who spent more time on reading the explanation about retrospective radiology research more frequently indicated no need for their approval to execute such studies. In fact, when including only those participants (32.0 per cent) who spent at least the minimum reading time to be able to comprehend the text (12.3 s), the preference for a waiver of consent increased by ten percentage points, to 41.0 per cent. This is also in line with the finding that a majority of patients do not read informed consent texts (Özhan et al. 2014). The variance in time spent on reading the explanation about retrospective radiology research can be explained by the fact that the participants previously answered several other questions related to radiology in this survey (that were not part of the present study) and that some participants may have been impatient or considered it unnecessary to read the full explanation. Younger respondents and respondents with a lower level of education were less likely to take (sufficient) time for reading the text than older and higher educated respondents. People who had completed a higher level of education also more frequently indicated informed consent to be unnecessary compared to lower educated people. This is in line with a large body of previous literature that has suggested that education leads to higher trust (cited in Wu 2021), where the Netherlands is in the top ten countries with a positive correlation, ranking close to smaller countries like Slovenia and Trinidad and Tobago, but also larger countries like the United States. Finally, it should be noted that participants’ view on the retrospective use of diagnostic radiology data was similar to their view on the retrospective use of interventional radiology data.
Our findings may have two potential practical implications. First, policymakers may perhaps be more lenient towards permitting the use of deidentified radiology data without requiring patient informed consent, provided the situation concerns a hospital setting and patients are well informed about what retrospective radiology research entails (in this situation, a substantial proportion of respondents indicated explicit patient consent to be unnecessary). This approach is not in line with the GDPR article 5, where it is stated that data that is “collected for specified, explicit and legitimate purposes and not further processed in a manner that is incompatible with those purposes” (European Commission 2022). However, studies have shown that, under certain conditions, people are nevertheless willing to share data for health research (Kalkman et al. 2022), and they are also less likely to revoke once having given consent (Kreuter et al. 2020). Therefore, patients may be assumed to have no objections to having their imaging data being retrospectively investigated unless indicated by an opt-out option that should be readily available to patients and visible to researchers. However, the passive nature of opt-out causes an opt-in procedure a preferred standard (Lutomski and Manders 2024). Moreover, opt-out procedures may increase administrative burden (Marcotte et al. 2023). In addition, for patients to be able to make a well-informed decision to make use of this opt-out option, hospitals or radiology departments may be encouraged to enclose additional information on this topic in patient brochures and/or pamphlets, and by verbal communication to those who undergo medical imaging. This information should be adapted to those with lower levels of education, as our research has shown lower educated people to be generally more reluctant towards letting researchers retrospectively investigate their imaging data. Especially interactive components in the informed consent process to facilitate understanding are important (Glaser et al. 2020). Second, for all other institutions that do not concern a hospital (i.e. universities not linked to a hospital, other non-commercial institutions, government agencies, and particularly commercial firms), the support for an informed consent waiver for retrospective radiology research drops dramatically, and for these institutions, it can be argued that an “opt-out option” would be inappropriate, and that all patients should be actively approached and asked for informed consent to use their imaging data.
This present study had some limitations. First, our study was performed among participants who can be considered representative of the Dutch population, and it remains unknown if our findings are also applicable to other countries. Second, our study did not investigate the general population’s view on more complex issues such as situations in which non-commercial investigators work together with commercial partners and when researchers aim to investigate imaging data linked to genetic data. Third, for the sake of not introducing too much complexity, we did not specifically inform participants about the difference between fully anonymized and pseudonymized data. Fourth, we speculated about potential practical implications of our findings (i.e., assumption of no patient objection for retrospective radiology research by hospitals unless indicated by patients and assumption of patient objection for retrospective radiology research by all other institutions unless explicitly permitted by patients), but whether or not the population would actually accept these scenarios remains unclear. Furthermore, it should also be emphasized that previous research on this topic has been completely lacking so far. Therefore, the results of our study should be considered as a baseline measurement of the general population’s view on retrospective radiology research and to serve as a basis for further studies.
In conclusion, the general population permits retrospective radiology research by hospitals, and a substantial proportion indicates explicit patient consent to be unnecessary when understanding what retrospective radiology research entails. However, the general population’s support for the unrestricted retrospective use of imaging data for research purposes without patient consent decreases for universities not linked to hospitals, other non-commercial institutions, government agencies, and particularly commercial firms.
Data Availability
All data is available online on the website of the LISS Panel, under project 322 via this link: https://www.dataarchive.lissdata.nl/study-units/view/1403.
References
Brysbaert, M., S. Longjiao, W. Duyck, and N. Dirix. 2021. Improving reading rate prediction with word length information: Evidence from Dutch. Quarterly Journal of Experimental Psychology 74(11): 2013–2018.
De Lange, D.W., B. Guidet, F.H. Andersen, et al. 2019. Huge variation in obtaining ethical permission for a non-interventional observational study in Europe. BMC Medical Ethics 20: 39.
European Commission. 2022. Data protection in the EU. https://ec.europa.eu/info/law/law-topic/data-protection/data-protection-eu_en. Accessed March 10, 2023.
Glaser, J., S. Nouri, A. Fernandez, et al. 2020. Interventions to improve patient comprehension in informed consent for medical and surgical procedures: an updated systematic review. Medical Decision Making 40(2): 119–143.
Junod, V., and B. Elger. 2010. Retrospective research: What are the ethical and legal requirements? Swiss Medical Weekly 140(0708): 1–10.
Kalkman, S., J. van Delden, A. Banerjee, B. Tyl, M. Mostert, and G. van Thiel. 2022. Patients’ and public views and attitudes towards the sharing of health data for research: A narrative review of the empirical evidence. Journal of Medical Ethics 48(1): 3–13.
Kreuter, F., G.C. Haas, F. Keusch, S. Bähr, and M. Trappmann. 2020. Collecting survey and smartphone sensor data with an app: Opportunities and challenges around privacy and informed consent. Social Science Computer Review 38(5): 533–549.
LISS Board of Overseers. 2022. https://www.lissdata.nl/how-it-works. Accessed March 10, 2023
Lutomski, J.E., and P. Manders. 2024. From opt-out to opt-in consent for secondary use of medical data and residual biomaterial: An evaluation using the RE-AIM framework. Plos One 19(3): e0299430.
Marcotte, L.M., S. Deeds, C. Wheat, et al. 2023. Automated opt-out vs opt-in patient outreach strategies for breast cancer screening: a randomized clinical trial. JAMA Internal Medicine 183(11): 1187–1194.
Milchenko, M., and D. Marcus. 2013. Obscuring surface anatomy in volumetric imaging data. Neuroinformatics 11: 65–75.
Özhan, M.Ö., M.A. Süzer, İ. Çomak, et al. 2014. Do the patients read the informed consent? Balkan Medical Journal 2014(2): 132–136.
Pinto Dos Santos, D., and B. Baeßler. 2018. Big data, artificial intelligence, and structured reporting. European Radiology Experimental 2: 42.
Stefánsson, E., O.Y. Atladóttir, and B.Gudbjornsson. 2008. Are ethics rules too strict in retrospective clinical studies? Acta Ophthalmologica 86(6): 588–590.
Scherpenzeel, A.C., and M. Das. 2010. “True” longitudinal and probability-based internet panels: Evidence from the Netherlands. Social and behavioral research and the internet: Advances in applied methods and research strategies, edited by M. Das, P. Ester, and L. Kaczmirek, 77–104. New York, NY: Routledge.
Sullivan, G.M., and R. Feinn. 2012. Using effect size—or Why the P value is not enough. Journal of Graduate Medical Education 4(3): 279–282.
U.S. Department of Health and Human Services. 2022. The HIPAA Privacy Rule. https://www.hhs.gov/hipaa/for-professionals/privacy/index.html#:~:text=The%20HIPAA%20Privacy%20Rule&text=The%20Rule%20requires%20appropriate%20safeguards,information%20without%20an%20individual's%20authorization. Accessed March 10, 2023
Wu, C. 2021. Education and social trust in global perspective. Sociological Perspectives 64(6): 1166–1186.
Funding
ODISSEI,Unnumbered grant,Marieke Haan
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors have no competing interests to declare that are relevant to the content of this article.
This research is part of a project funded by the Open Data Infrastructure for Social Science and Economic Innovations (ODISSEI) in the Netherlands.
Ethical approval for the procedures in the LISS Panel was given by the board of overseers (LISS Board of Overseers 2022).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ongena, Y., Kwee, T.C., Yakar, D. et al. Retrospective Radiology Research: Do We Need Informed Patient Consent?. Bioethical Inquiry (2024). https://doi.org/10.1007/s11673-024-10368-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11673-024-10368-6